FDA Requires Label Changes for Benzos
Benzodiazepines are 'commonly abused and misused, often together with opioid pain relievers and other medicines, alcohol, and illicit drugs.'
Category: Prescription Drugs
Prescription Drugs
Latest
Prescription Drugs
Latest
Ambien Dosage for Women Adjusted in 2013, But Sex Bias in Drug Trials Persists to This Day
New findings confirm the persistence of a drug dose gender gap stemming from a historic disregard of the biological differences between male and female bodies.
Prescription Drugs
Popular
Narcolepsy May Not Look the Way You Would Expect
Narcolepsy, a relatively rare and poorly understood neurological condition, can be hard to diagnose. Julea Steiner was misdiagnosed for years before a sleep study helped doctors recognize her symptoms—excessive daytime sleepiness, vivid dreams, hallucinations, and mild cataplexy—as narcolepsy.
Insomnia Medication Prescriptions Increase with Spread of Coronavirus
Research from Express Scripts reveals the coronavirus is making a significant impact on mental health.
Read MorePaper Reviews Mechanisms of Action of Medications for Narcolepsy
Sleep Medicine has published an article that reviews the mechanism of action of available treatments for patients with narcolepsy.
Read MoreSolriamfetol Improves Quality of Life in People With Narcolepsy
Solriamfetol, a dopamine and norepinephrine reuptake inhibitor, offers short-term improvements in health-related quality of life (HRQoL), and work productivity in people with narcolepsy, according to study results published in Sleep Medicine.
Read MoreIs the Antidepressant Trazodone Safe for Insomnia Patients?
The antidepressant trazodone is commonly prescribed to treat insomnia. An article by Consumer Reports looks into the safety of this practice. A handful of studies have shown that trazodone may improve sleep during the first...
Read MoreThe Truth About Sleep Medications: Consumer Reports
Prescription sleep medication may only increase sleep time by about 20 to 30 minutes. All prescription sleep medications come with risks, including drowsiness the next day. Some have also been linked to sleepwalking and...
Read More
Insomnia and Alzheimer’s Disease: A New Randomized Trial Provides Data on the Efficacy and Safety of BELSOMRA (suvorexant) C-IV
The Merck-funded trial brought patients into the sleep lab to determine whether total sleep time...
Read MoreChronic Opioids and Sleep: What Prescribers Need to Know
There are a lot of issues with sleep going unnoticed, reports MedPage Today.”Poor sleep highlights pain. It makes pain worse and makes you more sensitized to pain, and you might take more opioids to alleviate that...
Read More
Prescribing Info Update: BELSOMRA Improves Total Sleep Time, WASO in Study of Mild-to-Moderate Alzheimer’s Disease Patients
Merck has received approval from the U.S. Food and Drug Administration (FDA) for an update to the...
Read MoreJazz Submits NDA for Lower-Sodium Narcolepsy Investigational Drug
Jazz Pharmaceuticals plc submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) on January 21, 2020, seeking marketing approval for JZP-258, an investigational medicine for the treatment of...
Read More
Survey: Your Narcolepsy Patients Don’t Necessarily Agree That Their Symptoms Are Controlled
Investigators surveyed health care providers as well as people with narcolepsy, and multiple...
Read MoreJazz Pharmaceuticals’ Sunosi Gets EU Marketing Authorization for Excessive Daytime Sleepiness in Narcolepsy or Obstructive Sleep Apnea
The European Commission has approved Jazz Pharmaceuticals plc’s Sunosi (solriamfetol) to improve wakefulness and reduce excessive daytime sleepiness (EDS) in adults with narcolepsy (with or without cataplexy) or...
Read More
FDA Approves Orexin Receptor Antagonist for Insomnia
The US Food and Drug Administration (FDA) has approved the new drug application for Eisai Co...
Read MoreNewly Approved Insomnia Drug Bests Zolpidem in Phase 3
Lemborexant emerged superior to placebo and to a commonly prescribed medication, zolpidem tartrate extended release, in a phase 3 randomized clinical trial of older adults with insomnia. Four days before release...
Read More
FDA Warns of Serious Breathing Problems with Gabapentinoids When Used with CNS Depressants or in Patients with Lung Problems
An FDA-approved drug for restless legs syndrome is included. The US Food and Drug Administration...
Read MoreProblem Drinking Linked to Higher Benzo Use
Problem drinkers are more likely than teetotalers and moderate drinkers to take benzodiazepines. When taken by heavier drinkers, benzodiazepines may heighten the risk for overdoses and accidents as well as exacerbate psychiatric...
Read More